OUR RESOURCES

Optimizing Treatment Outcomes in Lung Cancer

Welcome & Introduction

Newer Paradigm in the Treatment of Resected EGFRm Early Lung Cancer

Panel Discussion | Managing Early Stage Lung Cancer Patients

Oncowin Head and Neck Cancer Meet - 1

Welcome Introduction

Where we are in 2022 for molecular prolifing of Head & Neck Cancers?

Panel Discussion - NACT in Head and Neck Cancer

Lung Cancer Connect 2022 - 6 March

Welcome & Introduction

Lorlatinib as front-line option in ALK+ mNSCLC

Per-operative Therapy-Neoadjuvant and Adjuvant Immunotherapy

Management of Non-Small Cell Lung Cancer

Welcome & Introduction

Segmentectony Versus Wedge Resection for Stage Non-Small Cell Lung Cancer A Meta analysis

Role of SBRT in Early Stage NSCLC

Lung Cancer Treatment Updates On 14 Oct

Welcome & Introduction

Role of Alecensa in 1L ALK+ NSCLC patients Beyond The Barriers

Real World Evidence Osimertinib as SoC in the management of EGFRm NSCLC